Mindfulness-based stress reduction significantly reduces anxiety, depression, and fatigue in breast cancer patients
Mindfulness Training May Improve Quality of Life in Breast Cancer
This meta-analysis of 20 studies involving 2534 patients found that mindfulness-based stress reduction (MBSR) significantly alleviated anxie…
A review of research suggests that mindfulness programs can help breast cancer patients manage anxiety, depression, and fatigue during treat…
Financial toxicity and food insecurity create a health-economic pathway impacting nutrition in women with cancer
Financial stress and food insecurity impact health for women with cancer
This mini review explores the link between financial toxicity, food insecurity, and nutritional vulnerability in women with cancer. The auth…
High medical costs and lack of reliable food sources can lead to malnutrition and fatigue in women fighting breast and gynecologic cancers.
Circulating microRNAs and lipidomic/metabolomic biomarkers show 0.92 SROC AUC for early breast cancer detection
Blood markers show promise for early breast cancer detection
This meta-analysis of 6,935 participants evaluated the diagnostic accuracy of circulating microRNAs and lipidomic/metabolomic biomarkers in …
A new analysis of 35 studies finds that blood-based biomarkers can detect early breast cancer with high accuracy, but more research is neede…
Pyrotinib-based regimen achieves pathological complete response after non-response to standard neoadjuvant therapy in HER2+ breast cancer
Case shows new drug combo may help breast cancer patient
This case report and literature review describes a patient with HER2+/HR+ breast cancer who achieved total pathological complete response af…
A woman with HER2-positive breast cancer achieved complete response after switching to a pyrotinib-based regimen when standard therapy faile…
Impact of Physical Activity Interventions on Exercise Levels in Breast Cancer Patients
Physical activity programs show promise for women with breast cancer
Meta-analysis reveals that structured physical activity programs significantly increase exercise levels in women with breast cancer over sho…
New research shows that exercise programs can increase physical activity levels for women living with or beyond a breast cancer diagnosis.
Discordant treatment responses between primary and metastatic sites occur in 25.1% of stage IV breast cancer
Treatment response differences between primary and metastatic sites impact survival
This exploratory analysis of a Phase III trial involved 271 patients with de novo stage IV breast cancer receiving primary systemic therapy.…
New data shows that when breast cancer responds differently at the original site versus other areas, it can affect patient outcomes.
Axillary lymph node dissection increases risk of arm swelling and lymphoedema in breast cancer patients
Trial Shows Axillary Surgery Predicts Long Term Arm Swelling
This randomized controlled trial of 469 patients undergoing surgery and radiotherapy for node-positive breast cancer found that axillary lym…
New research shows that axillary lymph node dissection is a primary predictor of long-term arm swelling for patients after breast cancer tre…
Essential oil interventions reduce acute nausea severity in patients with chemotherapy-induced breast cancer symptoms
Essential oils may reduce chemotherapy nausea in breast cancer patients
This systematic review and meta-analysis of essential oil-based interventions for breast cancer patients receiving chemotherapy found a sign…
Essential oil treatments like peppermint extract could help ease severe nausea for women undergoing chemotherapy for breast cancer.
Internal mammary and medial-supraclavicular irradiation reduces breast cancer mortality without improving overall survival
Trial shows specific radiation reduces breast cancer deaths over 20 years
This trial evaluated internal mammary and medial-supraclavicular irradiation for patients with early stage breast cancer. While the interven…
A long-term study of over 4,000 women found that a specific radiation technique lowered breast cancer deaths but did not change overall surv…
Paclitaxel arm achieves 56.4% pathologic complete response compared to 23.7% with endocrine therapy
Trial shows chemotherapy helps shrink early breast cancer more effectively
This Phase II multicenter randomized trial evaluated neoadjuvant trastuzumab and pertuzumab combined with either endocrine therapy or paclit…
A new trial compares using standard chemotherapy versus hormone therapy to shrink tumors before surgery in patients with HER2-positive breas…
HR-positive HER2-low breast cancer accounts for 60% of cases; deruxtecan reshapes treatment
New drug class reshapes treatment for common breast cancer type
This systematic review examines HR-positive HER2-low-expressing breast cancer, noting it accounts for nearly 60% of breast cancer incidence.…
Nearly 60% of breast cancers are HR-positive HER2-low. A new drug class is changing how they're treated.
AI plus celecoxib more than doubles odds of clinical response in ER-positive breast cancer
Adding celecoxib to hormone therapy improves early breast cancer response
This Phase III randomized trial of 269 postmenopausal women with ER-positive resectable breast cancer found that adding celecoxib to an arom…
A new trial shows that adding the drug celecoxib to standard hormone therapy can improve initial clinical responses in postmenopausal women …
Questions about Breast Cancer
Is there any research on using AI for Breast Cancer pathology?
Yes, AI is being researched for breast cancer pathology, including digital pathology, deep learning for imaging, and machine learning for biomarker detection.
Full answer →Can a plasma lipid panel help detect early stage Breast Cancer?
Yes, early research shows plasma lipid panels can help detect early-stage breast cancer, with machine learning models achieving high accuracy, but they are not yet standard clinical tests.
Full answer →What are the new treatments for triple-negative and HER2-positive Breast Cancer?
New treatments for triple-negative breast cancer include chemo-immunotherapy (pembrolizumab plus platinum-based chemo) and potential NY-ESO-1 targeted therapies; for HER2-positive breast cancer, neoadjuvant targeted combinations and post-neoadjuvant trastuzumab emtansine are key
Full answer →Does the PECS II block reduce morphine use after Breast Cancer surgery?
Yes, the PECS II block significantly reduces morphine use after breast cancer surgery, based on multiple randomized trials and a meta-analysis.
Full answer →Can deep learning help doctors find Breast Cancer on tomosynthesis scans?
Yes, deep learning can help doctors find breast cancer on tomosynthesis scans, matching or improving radiologist accuracy in some cases.
Full answer →All Breast Cancer Articles
- Mindfulness-based stress reduction significantly reduces anxiety, depression, and fatigue in breast cancer patients
- Financial toxicity and food insecurity create a health-economic pathway impacting nutrition in women with cancer
- Circulating microRNAs and lipidomic/metabolomic biomarkers show 0.92 SROC AUC for early breast cancer detection
- Pyrotinib-based regimen achieves pathological complete response after non-response to standard neoadjuvant therapy in HER2+ breast cancer
- Discordant treatment responses between primary and metastatic sites occur in 25.1% of stage IV breast cancer
- Impact of Physical Activity Interventions on Exercise Levels in Breast Cancer Patients
- Axillary lymph node dissection increases risk of arm swelling and lymphoedema in breast cancer patients
- Essential oil interventions reduce acute nausea severity in patients with chemotherapy-induced breast cancer symptoms
- Internal mammary and medial-supraclavicular irradiation reduces breast cancer mortality without improving overall survival
- Paclitaxel arm achieves 56.4% pathologic complete response compared to 23.7% with endocrine therapy
- AI plus celecoxib more than doubles odds of clinical response in ER-positive breast cancer
- AI diagnostic tools show high accuracy but limited real-world validation in systematic review
- HR-positive HER2-low breast cancer accounts for 60% of cases; deruxtecan reshapes treatment
- Doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy significantly suppresses tumor volume in breast cancer xenograft models
- Multi-method approach increases detection of nonadherent patients by 49.4%-69.0% in breast cancer
- Neoadjuvant chemotherapy with angiogenesis inhibitors increases pathological complete response rates in triple-negative breast cancer
- Tamoxifen reduces distant recurrence risk by HR 0.37 in PR-positive postmenopausal breast cancer
- Chinese herbal decoctions YHHYT, BZT, and FJHQT show varying efficacy for breast cancer treatment outcomes
- Tamoxifen improves 20-year distant recurrence-free interval for Luminal A and B breast cancer
- Sugar sweetened beverages and orange juice are associated with increased risk of several cancer types
- KYR intervention is non-inferior to conventional genetic counseling in breast cancer risk knowledge
- SYHX2011 improves objective response rate to 35.8% compared to 25.8% for PAB in breast cancer
- Tai Chi Chih, cognitive behavioral therapy, and massage therapy reduce cancer-related fatigue in breast cancer
- Structured education plus entertainment therapy reduces anxiety by 3.45 points on SAS scale
- DHP107 noninferior to intravenous paclitaxel in HER2-negative, metastatic breast cancer
- Magnetic seed localization is noninferior to radioguided occult lesion localization for margin negativity
- Evaluating Concurrent versus Sequential Radiation Boosts for Ipsilateral Breast Recurrence Prevention
- Local or regional anaesthesia shows no significant difference in overall survival for breast cancer patients
- Circulating cfDNA shows high diagnostic accuracy for breast cancer in meta-analysis
- Health education improves self-efficacy and quality of life for patients with breast cancer
- Healthy diet significantly decreases C-reactive protein levels in women with breast cancer
- Autologous fat grafting provides moderate volume retention and improved patient-reported outcomes in postmastectomy reconstruction
- Acupuncture Efficacy in Managing Cancer Related Fatigue and Quality of Life
- High PTTG1 expression correlates with poorer survival and advanced disease in various solid tumors
- Low baseline TKa associated with longer OS of 38.5 months in endocrine-resistant MBC
- HPV prevalence in breast cancer tissue is 23% with higher risk in specific subtypes
- Curcumin reduces tumor weight and volume in preclinical models of breast cancer
- High mammography awareness and partner support are linked to breast cancer screening behaviors
- Explainable AI methods aim to improve deep learning interpretability in breast cancer ultrasound
- Perioperative nursing training protocol improves satisfaction in implant-based breast reconstruction
- Evaluating ctDNA Dynamics as Prognostic Biomarkers in Advanced HR+ HER2- Breast Cancer
- DeSTIL-positive HER2+ breast cancer patients show HR 0.09 for event-free survival with trastuzumab
- WBRT yields median survival of 3.6 months in Nigerian brain metastases patients
- Olanzapine significantly improves complete response and total control in chemotherapy-induced nausea for breast cancer
- Tucatinib plus trastuzumab and pertuzumab improves median PFS to 24.9 months in HER2+ MBC
- THP shows noninferior pCR rates compared to TCbHP in HER2-positive invasive breast cancer
- OTUD7B acts as a context-dependent regulator in various cancers and inflammatory conditions
- Modified pectoral plane block (PECS II) provides longer analgesia duration and lower morphine use
- 26 Gy in 5 fractions non-inferior to 40 Gy in 15 fractions for breast cancer recurrence at 10 years
- Datopotamab deruxtecan showed no overall survival benefit versus investigator's choice chemotherapy in metastatic HR-positive breast cancer.
- Immunotherapy improves complete response but lacks overall response benefit in HR+ breast cancer
- Trastuzumab deruxtecan improves PFS vs chemotherapy in HR-positive, HER2-low breast cancer
- CE-MRI rules out malignancy in 13.1% pretest probability for high-risk breast lesions with 91.3% sensitivity
- TAC chemotherapy improves relapse-free survival in certain early breast cancer subtypes
- Meta-analysis finds higher complication rates with immediate versus delayed breast reconstruction
- Meta-analysis of CDK4/6 inhibitor rechallenge shows improved progression-free survival in advanced breast cancer
- Narrative review examines microorganisms in breast cancer with limited evidence from cross-sectional studies and models
- Review explores host-microbiome interactions in breast cancer
- Fulvestrant maintenance improves PFS versus capecitabine in HR+ HER2- metastatic breast cancer
- Systematic review and network meta-analysis on exercise dose for cancer-related fatigue in breast cancer survivors
- Narrative review of lung, breast, liver, and kidney cancer evidence
- Network meta-analysis of interventions for oral mucositis in breast cancer patients
- Review covers capecitabine and trastuzumab emtansine for triple-negative and HER2-positive breast cancer
- Deep learning matches radiologists in breast cancer detection using tomosynthesis
- Radiofrequency ablation followed by radiation therapy shows noninferior 5-year recurrence-free survival compared to partial mastectomy in early stage breast cancer
- Meta-analysis evaluates high-intensity focused ultrasound for primary breast cancer treatment
- CDK4/6 inhibitors plus endocrine therapy improve survival in advanced hormone receptor-positive breast cancer
- In-person group sessions boost fruit/vegetable intake in Latina breast cancer survivors
- Higher shoulder joint radiation dose linked to worse arm morbidity in breast cancer patients with SLN macrometastases
- Systematic review of post-traumatic growth in 6382 breast cancer patients
- Systematic review and meta-analysis of axillary staging in node-positive breast cancer patients
- Network meta-analysis shows exercise interventions improve cognitive function in breast cancer patients
- Case report and literature review of severe adverse reactions following pucotenlimab treatment
- Network meta-analysis compares exercise modalities for quality of life in breast cancer survivors
- Histology-derived gene-expression signatures predict distant recurrence-free interval and chemotherapy benefit in early breast cancer cohorts
- Narrative review on AI and digital pathology for breast and gynecologic cancers
- Plasma lipid panel and machine learning for non-invasive early breast cancer detection
- CDK4/6i plus AI or fulvestrant shows similar clinical benefit in HR+ HER2- MBC
- Narrative review discusses mitochondria and immune crosstalk in breast cancer patients
- Perioperative Propranolol and Etodolac Safety and 8-Year Survival in Cancer Patients
- Gedatolisib plus fulvestrant with or without palbociclib improved progression-free survival versus fulvestrant monotherapy in advanced breast cancer
- Narrative review offers insights for managing breast cancer survivors with cardiovascular diseases
- Peer-led blended peer support program improves psychosocial adjustment in young- to middle-aged breast cancer patients
- Meta-analysis finds oral SERDs improve PFS over standard ET in HR+ HER2- ABC
- Tucidinostat plus capecitabine shows 25.8% response in advanced HR-positive HER2-negative breast cancer
- Combined exercise shows highest probability of reducing inflammatory markers in breast cancer survivors
- Meta-analysis links BMI to breast cancer subtype risk with menopausal status differences
- Mepitel Film showed no difference versus StrataXRT for moist desquamation in breast cancer patients receiving adjuvant radiation therapy
- Meta-analysis of 12 studies reports chemotherapy-induced nausea and vomiting prevalence and risk factors in breast cancer patients
- IC-ECG-guided port placement in three breast cancer patients with PLSVC showed no complications
- Alcohol consumption increases breast cancer incidence risk in women with varying intake levels
- Imlunestrant shows OS benefit in ESR1-mutated advanced breast cancer in Phase III trial
- Axillary ultrasound did not improve sentinel lymph node detection rates compared to clinical examination alone in early-stage breast cancer patients
- Network meta-analysis of adjuvant chemotherapy regimens for early-stage breast cancer identifies optimal dosing sequences and safety profiles
- Digital and AI-supported psychosocial interventions modestly reduce distress and improve quality of life in women with breast cancer
- Meta-analysis finds [68Ga]Ga-FAPI PET shows high diagnostic accuracy for gynecologic cancers
- Umbrella review finds convincing evidence linking former smoking to increased breast cancer risk
- Losartan reduces incidence and delays onset of paclitaxel-induced peripheral neuropathy in women with early-stage breast cancer
- Oral paclitaxel shows similar efficacy to IV paclitaxel in phase II metastatic breast cancer trial
- DIBH reduces radiation dose to heart and lungs in left-sided breast cancer VMAT
- Hypofractionated stereotactic radiation therapy showed high local control in breast cancer brain metastases
- Meta-analysis finds BMI affects pCR rates in breast cancer patients receiving neoadjuvant chemotherapy
- NAUTILUS RCT reports 11.2% ALN metastasis rate in SLNB arm for cT1-2/N0 breast cancer
- Aerobic exercise correlates with BDNF methylation changes and cognitive improvements in breast cancer survivors
- Single-fraction stereotactic partial breast irradiation shows promising early control in early-stage breast cancer